News

DoP further extends timeline to apply for support under PLI scheme for bulk drugs: Gireesh Babu, New Delhi Wednesday, July 9, 2025, 08:00 Hrs [IST] The Department of Pharmaceutica ...
Antibody–siRNA conjugates (ARCs) are a type of promising drug modalities for cancer therapy. However, initial reports of ARCs present the gene knockdown effect only in limited tissues (e.g., muscles) ...